agilon health's (AGL) "Hold" Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of agilon health (NYSE:AGL - Free Report) in a report published on Friday,Benzinga reports.

Other equities research analysts have also issued reports about the company. Stifel Nicolaus raised their target price on agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research report on Wednesday, February 26th. Citigroup upgraded shares of agilon health from a "sell" rating to a "neutral" rating and raised their price objective for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Royal Bank of Canada boosted their target price on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Macquarie started coverage on shares of agilon health in a research note on Monday, December 16th. They set a "neutral" rating and a $3.00 price target for the company. Finally, Sanford C. Bernstein upped their price objective on agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a research note on Wednesday, January 15th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $3.95.

Remove Ads

agilon health Stock Performance

Shares of NYSE AGL traded down $0.01 during midday trading on Friday, reaching $4.47. The company's stock had a trading volume of 3,681,686 shares, compared to its average volume of 4,620,713. The stock has a market capitalization of $1.84 billion, a P/E ratio of -4.76 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a 50 day moving average price of $3.58 and a 200-day moving average price of $2.95. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Capital International Investors raised its position in shares of agilon health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after buying an additional 9,346,295 shares in the last quarter. Millennium Management LLC increased its stake in agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after acquiring an additional 4,706,357 shares during the last quarter. Citigroup Inc. raised its holdings in shares of agilon health by 2,251.5% in the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after acquiring an additional 1,941,993 shares in the last quarter. Algert Global LLC boosted its position in shares of agilon health by 1,042.7% during the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after acquiring an additional 1,924,157 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of agilon health by 49.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after acquiring an additional 1,498,524 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.